loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Palovarotene, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Palovarotene

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 410528-02-8, Rg-667, Ro-3300074, Sohonos, Clm-001, Ipn60120
    Molecular Formula
    C27H30N2O2
    Molecular Weight
    414.5  g/mol
    InChI Key
    YTFHCXIPDIHOIA-DHZHZOJOSA-N
    FDA UNII
    28K6I5M16G
    Palovarotene is an orally available, selective retinoic acid receptor gamma agonist. Palovarotene selectively binds to the gamma retinoid agonist, thereby reducing inflammation and enhancing repair.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid
    2.1.2 InChI
    InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+
    2.1.3 InChI Key
    YTFHCXIPDIHOIA-DHZHZOJOSA-N
    2.1.4 Canonical SMILES
    CC1(CCC(C2=C1C=C(C(=C2)C=CC3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
    2.1.5 Isomeric SMILES
    CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
    2.2 Other Identifiers
    2.2.1 UNII
    28K6I5M16G
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. R-667

    2. Rg-667

    3. Ro-3300074

    2.3.2 Depositor-Supplied Synonyms

    1. 410528-02-8

    2. Rg-667

    3. Ro-3300074

    4. Sohonos

    5. Clm-001

    6. Ipn60120

    7. R-667

    8. R 667

    9. Ipn-60120

    10. Ro 3300074

    11. Ro3300074

    12. 4-((1e)-2-(5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic Acid

    13. 4-[(e)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic Acid

    14. 28k6i5m16g

    15. (e)-4-(2-(3-((1h-pyrazol-1-yl)methyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic Acid

    16. Benzoic Acid, 4-((1e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-2-naphthalenyl)ethenyl)-

    17. Palovarotene [usan]

    18. Palovarotene [usan:inn]

    19. Unii-28k6i5m16g

    20. Palovarotene(r 667)

    21. Palovarotene (usan/inn)

    22. Palovarotene [inn]

    23. Palovarotene [jan]

    24. Palovarotene [who-dd]

    25. Gtpl8276

    26. Schembl4658931

    27. Chembl2105648

    28. Chebi:188559

    29. Dtxsid301025696

    30. Bcp16664

    31. Ex-a3101

    32. Who 9025

    33. Zb1580

    34. Zinc38467831

    35. Cs-2031

    36. Db12320

    37. Ac-36331

    38. Hy-14799

    39. R667

    40. R 667;ro 3300074

    41. D09365

    42. 528p028

    43. A914214

    44. Q15708269

    45. 4-[(e)-2-(5,5,8,8-tetramethyl-3-pyrazol-1-ylmethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)vinyl]benzoic Acid

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 414.5 g/mol
    Molecular Formula C27H30N2O2
    XLogP36.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count5
    Exact Mass414.230728204 g/mol
    Monoisotopic Mass414.230728204 g/mol
    Topological Polar Surface Area55.1 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity662
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in emphysema.

    Treatment of multiple osteochondromas

    Treatment of fibrodysplasia ossificans progressiva

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema.

    5.2 ATC Code

    M - Musculo-skeletal system

    M09 - Other drugs for disorders of the musculo-skeletal system

    M09A - Other drugs for disorders of the musculo-skeletal system

    M09AX - Other drugs for disorders of the musculo-skeletal system

    M09AX11 - Palovarotene

    5.3 Mechanism of Action

    Gamma-selective retinoic acid receptor agonist.

    Post Enquiry
    POST ENQUIRY